OD-OS Achieves Revocation of Iridex MicroPulse Patent and Clears Path to Tissue-Friendly Treatment with Navilas® in Clinical Practice

The Navilas® Laser System makes tissue-sparing treatment of retinal diseases more predictable, and paves the way for widespread adoption of microsecond pulse protocols in standard clinical practice.

OD-OS, the global leader in the development and commercialization of navigated retinal laser...

Softwareentwickler und Firmwareentwickler gesucht

Verstärken Sie unser Team.

 

 

The Navilas® Retina Laser Makes Microsecond Pulsing Treatment Predictable and Reproducible – Software Release 3.4

OD-OS, the global leader in the development and commercialization of navigated retinal laser...

New Website Informs Diabetics about the Navigated Laser Treatment of Vision-Threatening Retinal Diseases

The new internet platform www.navilas.com informs diabetics and their relatives comprehensively...

Experiences from a Retina Practice in Hawaii: Managing a Special Patient Population

Dr. Marc Tafoya runs a retina specialty practice in Waipahu, Hawaii. In this interview, he explains...

OD-OS Software Update for Navilas® 577+ and Navilas® 532 Benefits Long-Term Customers

OD-OS, the global leader in the development and commercialization of navigated retinal laser...

Laserkoagulationstherapie einfacher erlernen mit navigiertem System

Navilas® erleichtert Schulung und verbessert Produktivität in der Praxis

Die konventionelle Laserkoagulation galt lange als Mittel der Wahl bei der Behandlung der...

Das Augenlicht erhalten: Neue Website informiert Diabetiker über die navigierte Laserbehandlung von Netzhauterkrankungen

Die neue Internetplattform www.navilas.de informiert Diabetiker und deren Angehörige verständlich...

Key Trends Impacting Retinal Laser Care in 2018

Where is retinal laser care heading in 2018? We have looked at results on “Preferences and Trends...

Dr. Lars Freisberg of Tulsa Retina Consultants Shares His Experience of Utilizing the Navilas Retina Laser System in a Private Practice.

In this interview, Dr. Freisberg explains how Navilas contributes to better time management in his ...

David M. Brown, MD, Talks About the Navilas Retina Laser and his Take Home Message from TREX-DME

At AAO 2017, OD-OS talked to David M. Brown, MD, of Retina Consultants Houston about his experiences...

At AAO 2017, OD-OS Announces New Framework for Remote Planning of Navigated Retinal Laser Treatments

NaviGATE opens up new possibilities of digital collaboration, transparency and standardization in...

At AAO 2017: How Tissue-Friendly Retinal Laser Treatment Can Be Approached with Navilas 577s

Tissue-friendly laser treatment with lower powered laser pulses or a train of extremely short...

OD-OS releases major software update for Navilas 577s

OD-OS, the global leader in the development and commercialization of navigated retinal laser...

OD-OS launches Pre-Planned PRP for its Navilas Laser System

OD-OS, the global leader in the development and commercialization of navigated retinal laser...

Erster navigierter Netzhautlaser in Baden-Württemberg

Artikel lesen

Compact Navilas® Laser System 577s Receives U.S. FDA Clearance

Introduction of a compact Navilas Laser System to bring the benefits of navigated retina laser into day-to-day clinical routine

OD-OS, the global leader in the development and commercialization of navigated laser...

Welcome to the age of smart laser - Das revolutionäre Navilas® Laser System 577s

Weltneuheit vorgestellt auf dem 114. DOG-Kongress 2016 in Berlin

Teltow, 28.09.2016

Pünktlich zum...

Wirtschaftsminister zu Besuch bei OD-OS

Wirtschafts- und Energieminister Albrecht Gerber informierte sich über die navigierte Netzhaut-Lasertherapie mit Navilas® bei der OD-OS GmbH in Teltow

Teltow – 11. Januar 2016

 

OD-OS, das weltweit führende Unternehmen in der navigierten...

Navilas® Laser System 577+ Receives U.S. FDA Clearance

OD-OS, the world leader in Navigated Retinal Imaging and Laser Treatment, today announced the...

Navilas 577+ receives the Ophthalmologist Innovation Award 2014

Artikel lesen

OD-OS presents novel Yellow 577nm Navilas Laser System with microsecond pulsing option at World Ophthalmic Congress in Tokyo

OD-OS, the world leader in navigated laser therapy for retinal disease management, announced today...

Multicenter Study Announced to Evaluate Novel Combination Therapy for Treatment of Diabetic Macular Edema

TREX-DME Trial to Validate Efficacy and Stability of Treatment with Navilas® Navigated Laser plus Ranibizumab

Teltow, Germany – OD-OS, the world leader in navigated laser therapy for retinal disease management,...

Navilas® Navigated Laser Plus anti-VEGF Combination Therapy for Diabetic Macular Edema Shown to Reduce Retreatment Rates by More Than 50% While Stabilizing Visual Acuity

Study Shows Novel Combination Treatment Superior to Anti-VEGF Therapy Alone

Teltow, Germany – OD-OS, the world leader in navigated laser therapy for retinal disease management,...

Sie wollen mehr über navigierte Lasertherapie erfahren?

Kontaktieren Sie das Navilas® Team